Investing $250K in Bristol Myers Squibb yields $10K/year but patent risks loom.

To earn $10,000 annually from Bristol Myers Squibb dividends, an investor needs about $250,000 at the current 3.94% yield, equating to nearly 4,000 shares. However, the company faces significant risks from patent expirations, especially on its top drug Eliquis, which could reduce revenue sharply by 2027-2028. Despite this, Bristol Myers Squibb has strong cash reserves and a growing portfolio of new drugs that may offset losses. Investors should monitor dividend coverage and pipeline developments closely to assess future payout stability.